Adicet Bio, Inc. (ACET)
 NASDAQ: ACET · Real-Time Price · USD
 0.7794
 +0.0289 (3.85%)
  At close: Oct 30, 2025, 4:00 PM EDT
0.7564
 -0.0230 (-2.95%)
  Pre-market: Oct 31, 2025, 4:11 AM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $126.03 million as of October 30, 2025. Its market cap has increased by 0.53% in one year.
Market Cap 
 126.03M
Enterprise Value 
 16.42M
1-Year Change 
 0.53%
Ranking 
 Category 
 Stock Price 
$0.78
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $126.03M, a decrease of -58.22%. That is a compound annual growth rate of -15.67%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 121.36M | 38.86% | 
| Dec 31, 2024 | 87.39M | 7.13% | 
| Dec 29, 2023 | 81.58M | -78.70% | 
| Dec 30, 2022 | 383.09M | -44.04% | 
| Dec 31, 2021 | 684.61M | 148.60% | 
| Dec 31, 2020 | 275.39M | -8.72% | 
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |